Lifeward issues $5.58M initial convertible notes; additional $5.58M contingent on milestones

Lifeward Ltd.

Initial $5.58M senior secured convertible notes at 8% interest, convertible at $5.40/share.
Additional $5.58M notes require 150% ReWalk unit sales growth or stock price ≥$13.80 for 10 days.
Warrants for 100% of conversion shares at $5.40 exercise price, 5-year term.
Beneficial ownership limited to 4.99%; exchange cap at 19.99% unless shareholder approval.
Oramed Pharmaceuticals acts as collateral agent for the transaction.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.